1. Home
  2. BCDA vs YJ Comparison

BCDA vs YJ Comparison

Compare BCDA & YJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • YJ
  • Stock Information
  • Founded
  • BCDA N/A
  • YJ 2015
  • Country
  • BCDA United States
  • YJ China
  • Employees
  • BCDA N/A
  • YJ N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • YJ Other Specialty Stores
  • Sector
  • BCDA Health Care
  • YJ Consumer Discretionary
  • Exchange
  • BCDA Nasdaq
  • YJ Nasdaq
  • Market Cap
  • BCDA 9.4M
  • YJ 8.8M
  • IPO Year
  • BCDA N/A
  • YJ 2019
  • Fundamental
  • Price
  • BCDA $2.32
  • YJ $1.57
  • Analyst Decision
  • BCDA Strong Buy
  • YJ
  • Analyst Count
  • BCDA 1
  • YJ 0
  • Target Price
  • BCDA $25.00
  • YJ N/A
  • AVG Volume (30 Days)
  • BCDA 102.2K
  • YJ 16.8K
  • Earning Date
  • BCDA 05-14-2025
  • YJ 06-10-2025
  • Dividend Yield
  • BCDA N/A
  • YJ N/A
  • EPS Growth
  • BCDA N/A
  • YJ N/A
  • EPS
  • BCDA N/A
  • YJ N/A
  • Revenue
  • BCDA $58,000.00
  • YJ $57,219,520.00
  • Revenue This Year
  • BCDA N/A
  • YJ N/A
  • Revenue Next Year
  • BCDA N/A
  • YJ N/A
  • P/E Ratio
  • BCDA N/A
  • YJ N/A
  • Revenue Growth
  • BCDA N/A
  • YJ N/A
  • 52 Week Low
  • BCDA $1.63
  • YJ $1.42
  • 52 Week High
  • BCDA $6.15
  • YJ $3.46
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 45.74
  • YJ 46.26
  • Support Level
  • BCDA $2.40
  • YJ $1.55
  • Resistance Level
  • BCDA $2.92
  • YJ $1.75
  • Average True Range (ATR)
  • BCDA 0.31
  • YJ 0.19
  • MACD
  • BCDA -0.00
  • YJ 0.00
  • Stochastic Oscillator
  • BCDA 9.28
  • YJ 27.76

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

Share on Social Networks: